Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 948-910-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
OECD TG 471 (Ames): Mutagenic in the Salmonella typhimurium reverse mutation assay in the presence of S9-mix.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 19 Apr 2019 - 16 May 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- July 21, 1997
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- Histidine locus (Salmonella typhimurium)
Thryptophan locus (Escherichia coli) - Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Details on mammalian cell type (if applicable):
- CELLS USED
- Type and source of cells: Trinova Biochem GmbH, Germany [Master culture from Dr. Bruce N. Ames (TA1535, TA1537, TA98, TA100)
- Suitability of cells: Recommended test system in international guidelines (e.g. OECD, EC).
MEDIA USED
- Type and composition of media, CO2 concentration, humidity level, temperature, if applicable: All incubations were carried out in a controlled environment at a temperature of 37.0 ± 1.0°C (actual range 35.7 - 37.7°C). The temperature was continuously monitored throughout the experiment. - Species / strain / cell type:
- E. coli WP2 uvr A
- Details on mammalian cell type (if applicable):
- CELLS USED
- Type and source of cells: Master culture from The National Collections of Industrial and Marine Bacteria, Aberdeen, UK (WP2uvrA)
- Suitability of cells: Recommended test system in international guidelines (e.g. OECD, EC). - Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- source of S9 : Trinova Biochem GmbH, Giessen, Germany
- method of preparation of S9 mix : male Sprague Dawley rats that had been injected intraperitoneally with Aroclor 1254 - Test concentrations with justification for top dose:
- Blue Tansy Oil was tested in the tester strains TA100 and WP2uvrA at concentrations of 1.7, 5.4, 17, 52, 164, 512, 1600 and 5000 µg/plate in the absence and presence of S9-mix. Based on the results of the dose-range finding test, the following dose-range was selected for the first mutation experiment with the tester strains, TA1535, TA1537 and TA98 in the absence of S9-mix: 5.4, 17, 52, 164, 512 and 1600 μg/plate and in the presence of S9-mix: 17, 52, 164, 512, 1600 and 5000 μg/plate.
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: A solubility test was performed based on visual assessment. The test item formed a clear dark blue solution DMSO. - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 2-nitrofluorene
- sodium azide
- methylmethanesulfonate
- other: ICR-191
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: triplicate
- Number of independent experiments : two
METHOD OF TREATMENT/ EXPOSURE:
- Cell density at seeding (if applicable): 10^9 cells/mL
- Test substance added in medium; in agar (plate incorporation)
TREATMENT AND HARVEST SCHEDULE:
- Exposure duration/duration of treatment: plates were inverted and incubated in the dark at 37.0 ± 1.0 °C for 48 ± 4 h
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method, e.g.: background growth inhibition;
- Any supplementary information relevant to cytotoxicity: defined as a decrease in the number of revertants, reduction of the bacterial background lawn and/or the presence of microcolonies - Rationale for test conditions:
- The study procedures described in this report were based on the most recent OECD and EC guidelines.
- Evaluation criteria:
- A test item is considered negative (not mutagenic) in the test if:
a) The total number of revertants in the tester strain TA100 or WP2uvrA is not greater than two times the concurrent vehicle control, and the total number of revertants in tester strains TA1535, TA1537 or TA98 is not greater than three times the concurrent vehicle control.
b) The negative response should be reproducible in at least one follow-up experiment.
A test item is considered positive (mutagenic) in the test if:
a) The total number of revertants in the tester strain TA100 or WP2uvrA is greater than two times the concurrent vehicle control, or the total number of revertants in tester strains TA1535, TA1537, TA98 is greater than three times the concurrent vehicle control.
b) In case a follow up experiment is performed when a positive response is observed in one of the tester strains, the positive response should be reproducible in at least one follow up experiment. - Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- other: Outside of laboratory historical control data ranges
- Remarks:
- The mean number of revertant colonies showed a characteristic number of revertants (2 colonies) when compared against historical control data (3 revertants), the validity of the test was considered to be not affected.
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation and time of the determination:
Precipitation of Blue Tansy Oil on the plates was observed at the start of the incubation period at concentrations of 1600 µg/plate and upwards in tester strain TA100 and WP2uvrA.
Precipitation of Blue Tansy Oil on the plates was observed at the end of the incubation period at the concentrations of 5000 µg/plate in tester strain TA100 in the absence and presence of S9-mix.
RANGE-FINDING/SCREENING STUDIES:
Selection of an adequate range of doses was based on a dose-range finding test with the strains TA100 and WP2uvrA, both with and without 5% (v/v) S9-mix. Eight concentrations, 1.7, 5.4, 17, 52, 164, 512, 1600 and 5000 µg/plate were tested in triplicate. The highest concentration of Blue Tansy Oil used in the subsequent mutation assays was 5000 µg/plate or the level at which the test item inhibited bacterial growth.
STUDY RESULTS
- Concurrent vehicle negative and positive control data :
The strain-specific positive control values were within the laboratory historical control data ranges indicating that the test conditions were adequate and that the metabolic activation system functioned properly.
The negative control values were within the laboratory historical control data ranges, except the response for TA1537 in the absence of S9-mix, first experiment. However since the mean number of revertant colonies showed a characteristic number of revertant colonies
(2 revertant colonies) when compared against relevant historical control data (3 revertant colonies), the validity of the test was considered to be not affected.
For all test methods and criteria for data analysis and interpretation:
- Concentration-response relationship where possible : In the presence of S9-mix, in tester strain TA98, the test item induced up to 3.8 and 2.6-fold, dose related increases in the number of revertant colonies compared to the solvent control in the first and second experiment, respectively.
Ames test:
- Signs of toxicity : Cytotoxicity, as evidenced by a decrease in the number of revertants, reduction of the bacterial background lawn and/or the presence of microcolonies, was observed in all tester strains in the absence and presence of S9-mix, except in tester strain WP2uvrA where no toxicity was observed at any of the dose levels tested.
- Individual plate counts : yes
- Mean number of revertant colonies per plate and standard deviation : refer to tables
HISTORICAL CONTROL DATA (with ranges, means and standard deviation, and 95% control limits for the distribution as well as the number of data)
- Positive historical control data: refer to tables
- Negative (solvent/vehicle) historical control data: refer to tables - Conclusions:
- Based on the results of the in vitro gene mutation study in bacteria for Blue tansy oil, it is concluded that the test substance is mutagenic in the Salmonella typhimurium reverse mutation assay in the presence of S9-mix. The test item is not mutagenic in the Escherichia coli reverse mutation assay.
- Executive summary:
The potential of of Blue Tansy Oil and/or its metabolites to induce gene mutations was examined in a OECD TG 471 study, under GLP conditions.
Blue Tansy Oil was examined in 4 Salmonella typhimurium strains; TA98, TA100, TA1535, and TA1537 and at the tryptophan locus of Escherichia coli (E. coli) strain WP2uvrA in the presence or absence of an exogenous mammalian metabolic activation system (S9), in two independent experiments.
Based on the results of the dose-range finding test, the test item was tested in the first mutation assay in the tester strains TA1535, TA1537 and TA98 at concentration ranges of 5.4 to 1600 µg/plate and 17 to 5000 µg/plate in the absence and presence of 5% (v/v) S9-mix respectively. Blue Tansy Oil did not precipitate on the plates at this dose level. Cytotoxicity, as evidenced by a decrease in the number of revertants, reduction of the bacterial background lawn and/or the presence of microcolonies, was observed in all tester strains in the absence and presence of S9-mix.
Based on the results of the dose-range finding test, the test item was tested in the first mutation assay in the tester strains TA1535, TA1537 and TA98 at concentration ranges of 5.4 to 1600 µg/plate and 17 to 5000 µg/plate in the absence and presence of 5% (v/v) S9-mix respectively. In the absence of S9-mix, no increases in the number of revertants were observed at any of the tester strains tested. In the presence of S9-mix, in tester strain TA98, the test item induced dose-related increases in the number of revertant colonies compared to the solvent control. The increases observed were above the laboratory historical control data range and up to 3.8- fold the concurrent control
In a follow up experiment, no increases in the number of revertants were observed at any of the tester strains tested, in the absence of S9-mix. In the presence of S9-mix, in tester strain TA98, the test item induced dose-related increases in the number of revertant colonies compared to the solvent control. The increases observed were above the laboratory historical control data range and up to 2.6- fold the concurrent control.
In this study, acceptable responses were obtained for the negative and strain-specific positive control items indicating that the test conditions were adequate and that the metabolic activation system functioned properly.
Based on the results of this study it is concluded that Blue Tansy Oil is mutagenic in the Salmonella typhimurium reverse mutation assay in the presence of S9-mix. The test item is not mutagenic in the Escherichia coli reverse mutation assay.
Reference
Experiment 1
(µg/plate) |
|
||
|
|
|
|
Without S9-mix
Positive control |
592 |
± |
55 |
|
1399 |
± |
91 |
|
|
|
|
|
Solvent control |
121 |
± |
4 |
|
37 |
± |
6 |
|
|
|
|
|
1.7 |
125 |
± |
6 |
|
31 |
± |
9 |
|
|
|
|
|
5.4 |
113 |
± |
5 |
|
32 |
± |
12 |
|
|
|
|
|
17 |
95 |
± |
7 |
|
25 |
± |
4 |
|
|
|
|
|
52 |
97 |
± |
16 |
n |
32 |
± |
7 |
|
|
|
|
|
164 |
91 |
± |
8 |
s |
33 |
± |
3 |
|
|
|
|
|
512 |
110 |
± |
13 |
m |
34 |
± |
5 |
|
|
|
|
|
1600 |
|
|
|
e NP MC |
32 |
± |
3 |
|
|
|
|
|
5000 |
|
|
|
e SP MC |
27 |
± |
5 |
n NP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
With S9-mix1
Positive control |
1593 |
± |
88 |
|
238 |
± |
54 |
|
|
|
|
|
Solvent control |
109 |
± |
9 |
|
31 |
± |
2 |
|
|
|
|
|
1.7 |
107 |
± |
16 |
|
45 |
± |
7 |
|
|
|
|
|
5.4 |
97 |
± |
10 |
|
31 |
± |
6 |
|
|
|
|
|
17 |
116 |
± |
21 |
|
35 |
± |
11 |
|
|
|
|
|
52 |
133 |
± |
12 |
|
38 |
± |
6 |
|
|
|
|
|
164 |
124 |
± |
6 |
|
37 |
± |
8 |
|
|
|
|
|
512 |
117 |
± |
17 |
n |
31 |
± |
7 |
|
|
|
|
|
1600 |
146 |
± |
22 |
s NP |
38 |
± |
15 |
|
|
|
|
|
5000 |
|
|
e SP MC |
28 |
± |
11 |
n NP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(µg/plate) |
|
||
|
|
|
|
Without S9-mix
Positive control |
1033 |
± |
27 |
|
999 |
± |
61 |
|
1072 |
± |
264 |
|
Solvent control |
10 |
± |
5 |
|
2 |
± |
1 |
|
11 |
± |
3 |
|
5.4 |
8 |
± |
3 |
|
4 |
± |
4 |
|
13 |
± |
4 |
|
17 |
8 |
± |
2 |
|
3 |
± |
2 |
|
10 |
± |
3 |
|
52 |
11 |
± |
5 |
n |
4 |
± |
1 |
n |
13 |
± |
3 |
|
164 |
7 |
± |
4 |
s |
2 |
± |
1 |
s |
16 |
± |
4 |
n |
512 |
6 |
± |
5 |
m |
2 |
± |
1 |
m |
12 |
± |
2 |
s |
1600 |
7 |
± |
3 |
m NP |
2 |
± |
2 |
m NP |
16 |
± |
6 |
s NP |
|
|
|
|
|
|
|
|
|
|
|
|
|
With S9-mix1
Positive control |
277 |
± |
17 |
|
402 |
± |
21 |
|
1329 |
± |
213 |
|
Solvent control |
14 |
± |
4 |
|
3 |
± |
2 |
|
14 |
± |
3 |
|
17 |
6 |
± |
4 |
|
5 |
± |
4 |
|
20 |
± |
8 |
|
52 |
7 |
± |
4 |
|
5 |
± |
4 |
|
17 |
± |
3 |
|
164 |
7 |
± |
4 |
|
4 |
± |
1 |
|
23 |
± |
3 |
|
512 |
10 |
± |
2 |
n |
5 |
± |
3 |
n |
28 |
± |
3 |
n |
1600 |
8 |
± |
6 |
s |
2 |
± |
3 |
m |
23 |
± |
6 |
s |
5000 |
4 |
± |
4 |
m NP |
2 |
± |
2 |
e NP MC |
53 |
± |
14 |
m NP |
|
|
|
|
|
|
|
|
|
|
|
|
|
Experiment 2
(µg/plate) |
|
||||
|
|
|
|
|
|
Without S9-mix
Positive control |
950 |
± |
51 |
|
798 |
± |
47 |
|
1165 |
± |
62 |
|
1049 |
± |
73 |
|
1577 |
± |
79 |
|
|
Solvent control |
11 |
± |
3 |
|
4 |
± |
3 |
|
11 |
± |
0 |
|
122 |
± |
4 |
|
20 |
± |
7 |
|
|
86 |
7 |
± |
6 |
|
4 |
± |
1 |
|
14 |
± |
3 |
|
106 |
± |
12 |
|
|
|
|
|
|
154 |
5 |
± |
4 |
|
3 |
± |
2 |
|
11 |
± |
5 |
|
97 |
± |
7 |
|
|
|
|
|
|
275 |
7 |
± |
3 |
n |
7 |
± |
6 |
|
10 |
± |
5 |
n |
108 |
± |
18 |
n |
23 |
± |
3 |
|
|
492 |
6 |
± |
3 |
s |
3 |
± |
2 |
n NP |
13 |
± |
4 |
s |
87 |
± |
7 |
m |
19 |
± |
4 |
|
|
878 |
5 |
± |
2 |
s NP |
3 |
± |
2 |
s SP |
18 |
± |
9 |
s NP |
114 |
± |
22 |
m NP |
17 |
± |
5 |
|
|
1568 |
4 |
± |
3 |
m SP |
6 |
± |
5 |
s SP |
16 |
± |
3 |
s SP |
93 |
± |
31 |
m SP |
19 |
± |
5 |
|
|
2800 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16 |
± |
2 |
|
|
5000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26 |
± |
7 |
n NP |
|
With S9-mix1
Positive control |
294 |
± |
16 |
|
441 |
± |
20 |
|
624 |
± |
19 |
|
1755 |
± |
314 |
|
333 |
± |
21 |
|
Solvent control |
11 |
± |
6 |
|
6 |
± |
3 |
|
16 |
± |
6 |
|
112 |
± |
3 |
|
28 |
± |
6 |
|
154 |
10 |
± |
1 |
|
3 |
± |
2 |
|
24 |
± |
2 |
|
130 |
± |
21 |
|
|
|
|
|
275 |
7 |
± |
3 |
|
5 |
± |
5 |
|
30 |
± |
10 |
|
136 |
± |
12 |
|
21 |
± |
11 |
|
492 |
9 |
± |
2 |
|
4 |
± |
3 |
|
30 |
± |
6 |
|
120 |
± |
2 |
|
30 |
± |
6 |
|
878 |
8 |
± |
7 |
|
5 |
± |
2 |
n |
22 |
± |
8 |
n |
118 |
± |
13 |
n NP |
33 |
± |
3 |
|
1568 |
6 |
± |
6 |
n NP |
5 |
± |
2 |
s NP |
27 |
± |
4 |
s NP |
140 |
± |
12 |
s SP |
20 |
± |
4 |
|
2800 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24 |
± |
4 |
|
5000 |
7 |
± |
2 |
s SP |
2 |
± |
1 |
m SP |
41 |
± |
6 |
m SP |
|
|
e SP MC |
19 |
± |
4 |
n NP |
1 |
Plate incorporation assay (10% S9) |
MC |
Microcolonies |
NP |
No precipitate |
SP |
Slight Precipitate |
e |
Bacterial background lawn extremely reduced |
m |
Bacterial background lawn moderately reduced |
n |
Normal bacterial background lawn |
s |
Bacterial background lawn slightly reduced |
Historical positive controls
|
TA1535 |
TA1537 |
TA98 |
TA100 |
WP2uvrA |
|||||
S9-mix |
- |
+ |
- |
+ |
- |
+ |
- |
+ |
- |
+ |
Range |
3 – 29 |
3 – 27 |
3 – 20 |
3 – 23 |
8 - 61 |
8 – 60 |
61 – 176 |
60 - 176 |
10 – 61 |
9 - 68 |
Mean |
10 |
11 |
6 |
6 |
16 |
22 |
112 |
108 |
27 |
33 |
SD |
3 |
3 |
2 |
3 |
5 |
7 |
18 |
21 |
8 |
9 |
n |
3303 |
3265 |
3232 |
3212 |
3251 |
3326 |
3336 |
3246 |
3021 |
2993 |
SD = Standard deviation
n = Number of observations
Historical control data from experiments performed between Apr 2016 and Apr 2019.
Historical negative controls
|
TA1535 |
TA1537 |
TA98 |
|||
S9-mix |
- |
+ |
- |
+ |
- |
+ |
Range |
128 – 1530 |
73 – 1481 |
58 – 1422 |
54 – 1239 |
365 – 1978 |
250 – 2018 |
Mean |
919 |
256 |
802 |
328 |
1305 |
910 |
SD |
172 |
122 |
362 |
154 |
236 |
355 |
n |
3215 |
3122 |
2777 |
3187 |
3202 |
3216 |
|
TA100 |
WP2uvrA |
||
S9-mix |
- |
+ |
- |
+ |
Range |
439 – 1993 |
408 - 2379 |
93 – 1999 |
109 - 1968 |
Mean |
907 |
1308 |
1073 |
437 |
SD |
167 |
386 |
537 |
158 |
n |
3231 |
3179 |
2923 |
2987 |
SD = Standard deviation
n = Number of observations
Historical control data from experiments performed between Apr 2016 and Apr 2019.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (positive)
Additional information
OECD TG 471
The potential of of Blue Tansy Oil and/or its metabolites to induce gene mutations was examined in a OECD TG 471 study, under GLP conditions.
Blue Tansy Oil was examined in 4 Salmonella typhimurium strains; TA98, TA100, TA1535, and TA1537 and at the tryptophan locus of Escherichia coli (E. coli) strain WP2uvrA in the presence or absence of an exogenous mammalian metabolic activation system (S9), in two independent experiments.
Based on the results of the dose-range finding test, the test item was tested in the first mutation assay in the tester strains TA1535, TA1537 and TA98 at concentration ranges of 5.4 to 1600 µg/plate and 17 to 5000 µg/plate in the absence and presence of 5% (v/v) S9-mix respectively. Blue Tansy Oil did not precipitate on the plates at this dose level. Cytotoxicity, as evidenced by a decrease in the number of revertants, reduction of the bacterial background lawn and/or the presence of microcolonies, was observed in all tester strains in the absence and presence of S9-mix.
Based on the results of the dose-range finding test, the test item was tested in the first mutation assay in the tester strains TA1535, TA1537 and TA98 at concentration ranges of 5.4 to 1600 µg/plate and 17 to 5000 µg/plate in the absence and presence of 5% (v/v) S9-mix respectively. In the absence of S9-mix, no increases in the number of revertants were observed at any of the tester strains tested. In the presence of S9-mix, in tester strain TA98, the test item induced dose-related increases in the number of revertant colonies compared to the solvent control. The increases observed were above the laboratory historical control data range and up to 3.8- fold the concurrent control
In a follow up experiment, no increases in the number of revertants were observed at any of the tester strains tested, in the absence of S9-mix. In the presence of S9-mix, in tester strain TA98, the test item induced dose-related increases in the number of revertant colonies compared to the solvent control. The increases observed were above the laboratory historical control data range and up to 2.6- fold the concurrent control.
In this study, acceptable responses were obtained for the negative and strain-specific positive control items indicating that the test conditions were adequate and that the metabolic activation system functioned properly.
Based on the results of this study it is concluded that Blue Tansy Oil is mutagenic in the Salmonella typhimurium reverse mutation assay in the presence of S9-mix. The test item is not mutagenic in the Escherichia coli reverse mutation assay.
Justification for classification or non-classification
Based on the results of the in vitro gene mutation study in bacteria for Blue tansy oil, it is concluded that the test item is mutagenic in the Salmonella typhimurium reverse mutation assay in the presence of S9-mix. The test item is not mutagenic in the Escherichia coli reverse mutation assay. Further evaluation in an in-vitro mammalian cytogenicity/micronucleus test and a gene mutation study before a (non-)classification can be given to this substance.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.